PPARGC1A and congestive heart failure: In summary, SFAS ameliorates CHF by restoring impaired fatty acid oxidation and replenishing ATP via the activation of the AMPK/PGC-1α/SIRT3 signaling pathway, while concurrently suppressing oxidative stress.